{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:09Z","timestamp":1792300269147,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/ncprheum0855","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T12:35:10Z","timestamp":1214915710000},"page":"404-412","source":"Crossref","is-referenced-by-count":449,"title":["Control of autoimmune diseases by the vitamin D endocrine system"],"prefix":"10.1038","volume":"4","author":[{"given":"Luciano","family":"Adorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"key":"BFncprheum0855_CR1","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","volume":"15","author":"HF Deluca","year":"2001","unstructured":"Deluca HF and Cantorna MT (2001) Vitamin D: its role and uses in immunology. Faseb J 15: 2579\u20132585","journal-title":"Faseb J"},{"key":"BFncprheum0855_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.nutr.23.011702.073114","volume":"23","author":"MD Griffin","year":"2003","unstructured":"Griffin MD  et al. (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23: 117\u2013145","journal-title":"Annu Rev Nutr"},{"key":"BFncprheum0855_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellimm.2005.04.013","volume":"233","author":"L Adorini","year":"2005","unstructured":"Adorini L (2005) Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 233: 115\u2013124","journal-title":"Cell Immunol"},{"key":"BFncprheum0855_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","volume":"97","author":"E van Etten","year":"2005","unstructured":"van Etten E and Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97: 93\u2013101","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFncprheum0855_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/ard.2007.069831","volume":"66","author":"Y Arnson","year":"2007","unstructured":"Arnson Y  et al. (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66: 1137\u20131142","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0855_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pbiomolbio.2006.02.020","volume":"92","author":"MT Cantorna","year":"2006","unstructured":"Cantorna MT (2006) Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 92: 60\u201364","journal-title":"Prog Biophys Mol Biol"},{"key":"BFncprheum0855_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.smim.2003.12.008","volume":"16","author":"L Adorini","year":"2004","unstructured":"Adorini L  et al. (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16: 127\u2013134","journal-title":"Semin Immunol"},{"key":"BFncprheum0855_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1365-2249.2000.01204.x","volume":"120","author":"L Overbergh","year":"2000","unstructured":"Overbergh L  et al. (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-\u03b1-hydroxylase in murine macrophages. Clin Exp Immunol 120: 139\u2013146","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0855_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu PT  et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770\u20131773","journal-title":"Science"},{"key":"BFncprheum0855_CR10","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.4049\/jimmunol.170.11.5382","volume":"170","author":"M Hewison","year":"2003","unstructured":"Hewison M  et al. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170: 5382\u20135390","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ni1433","volume":"8","author":"H Sigmundsdottir","year":"2007","unstructured":"Sigmundsdottir H  et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285\u2013293","journal-title":"Nat Immunol"},{"key":"BFncprheum0855_CR12","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1172\/JCI114609","volume":"85","author":"J Cadranel","year":"1990","unstructured":"Cadranel J  et al. (1990) 1,25(OH)2D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 85: 1588\u20131593","journal-title":"J Clin Invest"},{"key":"BFncprheum0855_CR13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","volume":"179","author":"S Chen","year":"2007","unstructured":"Chen S  et al. (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179: 1634\u20131647","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266\u2013281","journal-title":"N Engl J Med"},{"key":"BFncprheum0855_CR15","unstructured":"Holick MF (2008) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol [10.1016\/j.annepidem.2007.12.001]"},{"key":"BFncprheum0855_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-642-55580-0_2","volume":"164","author":"C Carlberg","year":"2003","unstructured":"Carlberg C (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164: 29\u201342","journal-title":"Recent Results Cancer Res"},{"key":"BFncprheum0855_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1172\/JCI30142","volume":"117","author":"J Schauber","year":"2007","unstructured":"Schauber J  et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803\u2013811","journal-title":"J Clin Invest"},{"key":"BFncprheum0855_CR18","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"TT Wang","year":"2004","unstructured":"Wang TT  et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909\u20132912","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR19","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","volume":"164","author":"G Penna","year":"2000","unstructured":"Penna G and Adorini L (2000) 1\u03b1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405\u20132411","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR20","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","volume":"106","author":"G Penna","year":"2005","unstructured":"Penna G  et al. (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3 . Blood 106: 3490\u20133497","journal-title":"Blood"},{"key":"BFncprheum0855_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","volume":"167","author":"S Gregori","year":"2001","unstructured":"Gregori S  et al. (2001) Regulatory T cells induced by 1\u03b1,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945\u20131953","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR22","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1073\/pnas.121172198","volume":"98","author":"MD Griffin","year":"2001","unstructured":"Griffin MD  et al. (2001) Dendritic cell modulation by 1\u03b1,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98: 6800\u20136805","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0855_CR23","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1073\/pnas.0506516102","volume":"102","author":"X Dong","year":"2005","unstructured":"Dong X  et al. (2005) Regulation of RelB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc Natl Acad Sci USA 102: 16007\u201316012","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0855_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","volume":"178","author":"G Penna","year":"2007","unstructured":"Penna G  et al. (2007) 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 178: 145\u2013153","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","volume":"23","author":"YJ Liu","year":"2005","unstructured":"Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275\u2013306","journal-title":"Annu Rev Immunol"},{"issue":"6 Suppl","key":"BFncprheum0855_CR26","first-page":"1704S","volume":"125","author":"JM Lemire","year":"1995","unstructured":"Lemire JM  et al. (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of TH1 functions. J Nutr 125 (6 Suppl): 1704S\u20131708S","journal-title":"J Nutr"},{"key":"BFncprheum0855_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q","volume":"30","author":"F Mattner","year":"2000","unstructured":"Mattner F  et al. (2000) Inhibition of TH1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30: 498\u2013508","journal-title":"Eur J Immunol"},{"key":"BFncprheum0855_CR28","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1128\/MCB.15.10.5789","volume":"15","author":"I Alroy","year":"1995","unstructured":"Alroy I  et al. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition NFATp\/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789\u20135799","journal-title":"Mol Cell Biol"},{"key":"BFncprheum0855_CR29","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6","volume":"28","author":"M Cippitelli","year":"1998","unstructured":"Cippitelli M and Santoni A (1998) Vitamin D3: a transcriptional modulator of the IFN-\u03b3 gene. Eur J Immunol 28: 3017\u20133030","journal-title":"Eur J Immunol"},{"key":"BFncprheum0855_CR30","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","volume":"167","author":"A Boonstra","year":"2001","unstructured":"Boonstra A  et al. (2001) 1\u03b1,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of TH2 cells. J Immunol 167: 4974\u20134980","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/jcb.10580","volume":"89","author":"BD Mahon","year":"2003","unstructured":"Mahon BD  et al. (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89: 922\u2013932","journal-title":"J Cell Biochem"},{"key":"BFncprheum0855_CR32","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.4049\/jimmunol.177.12.8504","volume":"177","author":"G Penna","year":"2006","unstructured":"Penna G  et al. (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J Immunol 177: 8504\u20138511","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman L (2007) A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139\u2013145","journal-title":"Nat Med"},{"key":"BFncprheum0855_CR34","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","volume":"51","author":"G Gregori","year":"2002","unstructured":"Gregori G  et al. (2002) A 1\u03b1,25-dihydroxyvitamin D3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes 51: 1367\u20131374","journal-title":"Diabetes"},{"key":"BFncprheum0855_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.20011629","volume":"195","author":"FJ Barrat","year":"2002","unstructured":"Barrat FJ  et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (TH1)- and TH2-inducing cytokines. J Exp Med 195: 603\u2013616","journal-title":"J Exp Med"},{"key":"BFncprheum0855_CR36","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.4049\/jimmunol.179.9.6273","volume":"179","author":"S Gorman","year":"2007","unstructured":"Gorman S  et al. (2007) Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 179: 6273\u20136283","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR37","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ  et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942\u2013949","journal-title":"Nat Med"},{"key":"BFncprheum0855_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","volume":"84","author":"HA Bischoff-Ferrari","year":"2006","unstructured":"Bischoff-Ferrari HA  et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18\u201328","journal-title":"Am J Clin Nutr"},{"key":"BFncprheum0855_CR39","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/153537020422901108","volume":"229","author":"MT Cantorna","year":"2004","unstructured":"Cantorna MT and Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229: 1136\u20131142","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFncprheum0855_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pbiomolbio.2006.02.013","volume":"92","author":"WB Grant","year":"2006","unstructured":"Grant WB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 92: 65\u201379","journal-title":"Prog Biophys Mol Biol"},{"key":"BFncprheum0855_CR41","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL  et al. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832\u20132838","journal-title":"JAMA"},{"key":"BFncprheum0855_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1345\/aph.1G513","volume":"40","author":"SJ Brown","year":"2006","unstructured":"Brown SJ (2006) The role of vitamin D in multiple sclerosis. Ann Pharmacother 40: 1158\u20131161","journal-title":"Ann Pharmacother"},{"key":"BFncprheum0855_CR43","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","volume":"358","author":"E Hypponen","year":"2001","unstructured":"Hypponen E  et al. (2001) Intake of vitamin D and risk of type 1 diabetes: a birth\u2013cohort study. Lancet 358: 1500\u20131503","journal-title":"Lancet"},{"key":"BFncprheum0855_CR44","doi-asserted-by":"crossref","unstructured":"Zipitis CS and Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child [10.1136\/adc.2007.128579]","DOI":"10.1136\/adc.2007.128579"},{"key":"BFncprheum0855_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/art.11434","volume":"50","author":"LA Merlino","year":"2004","unstructured":"Merlino LA  et al. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50: 72\u201377","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0855_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","volume":"5","author":"DL Kamen","year":"2006","unstructured":"Kamen DL  et al. (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5: 114\u2013117","journal-title":"Autoimmun Rev"},{"key":"BFncprheum0855_CR47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/ard.2007.072736","volume":"67","author":"KH Costenbader","year":"2008","unstructured":"Costenbader KH  et al. (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 67: 530\u2013535","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0855_CR48","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/01.mib.0000236929.74040.b0","volume":"12","author":"HM Pappa","year":"2006","unstructured":"Pappa HM  et al. (2006) Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12: 1162\u20131174","journal-title":"Inflamm Bowel Dis"},{"key":"BFncprheum0855_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gene.2004.05.014","volume":"338","author":"AG Uitterlinden","year":"2004","unstructured":"Uitterlinden AG  et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143\u2013156","journal-title":"Gene"},{"key":"BFncprheum0855_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2006.02.016","volume":"371","author":"JM Valdivielso","year":"2006","unstructured":"Valdivielso JM and Fernandez E (2006) Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 371: 1\u201312","journal-title":"Clin Chim Acta"},{"key":"BFncprheum0855_CR51","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1210\/er.2004-0002","volume":"26","author":"S Nagpal","year":"2005","unstructured":"Nagpal S  et al. (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662\u2013687","journal-title":"Endocr Rev"},{"key":"BFncprheum0855_CR52","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0140-6736(07)61129-5","volume":"370","author":"A Menter","year":"2007","unstructured":"Menter A and Griffiths CE (2007) Current and future management of psoriasis. Lancet 370: 272\u2013284","journal-title":"Lancet"},{"key":"BFncprheum0855_CR53","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI25901","volume":"116","author":"Y Ma","year":"2006","unstructured":"Ma Y  et al. (2006) Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest 116: 892\u2013904","journal-title":"J Clin Invest"},{"key":"BFncprheum0855_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jn\/128.1.68","volume":"128","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT  et al. (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128: 68\u201372","journal-title":"J Nutr"},{"key":"BFncprheum0855_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1365-2249.1998.00706.x","volume":"114","author":"P Larsson","year":"1998","unstructured":"Larsson P  et al. (1998) A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114: 277\u2013283","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0855_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/ar12","volume":"1","author":"LC Tetlow","year":"1999","unstructured":"Tetlow LC and Woolley DE (1999) The effects of 1 alpha,25-dihydroxyvitamin D3 on matrix metalloproteinase and prostaglandin E2 production by cells of the rheumatoid lesion. Arthritis Res 1: 63\u201370","journal-title":"Arthritis Res"},{"key":"BFncprheum0855_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.autrev.2007.07.001","volume":"7","author":"M Cutolo","year":"2007","unstructured":"Cutolo M  et al. (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7: 59\u201364","journal-title":"Autoimmun Rev"},{"key":"BFncprheum0855_CR58","first-page":"453","volume":"17","author":"Z Andjelkovic","year":"1999","unstructured":"Andjelkovic Z  et al. (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17: 453\u2013456","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0855_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1568-9972(03)00062-4","volume":"3","author":"ML Santiago-Raber","year":"2004","unstructured":"Santiago-Raber ML  et al. (2004) Genetic basis of murine lupus. Autoimmun Rev 3: 33\u201339","journal-title":"Autoimmun Rev"},{"key":"BFncprheum0855_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3177\/jnsv.36.21","volume":"36","author":"J Abe","year":"1990","unstructured":"Abe J  et al. (1990) Prevention of immunological disorders in MRL\/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 \u03b1,25-dihydroxyvitamin D3 . J Nutr Sci Vitaminol (Tokyo) 36: 21\u201331","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"BFncprheum0855_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/08916939209150321","volume":"12","author":"JM Lemire","year":"1992","unstructured":"Lemire JM  et al. (1992) 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice. Autoimmunity 12: 143\u2013148","journal-title":"Autoimmunity"},{"key":"BFncprheum0855_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/clim.2000.4998","volume":"99","author":"M Linker-Israeli","year":"2001","unstructured":"Linker-Israeli M  et al. (2001) Vitamin D3 and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 99: 82\u201393","journal-title":"Clin Immunol"},{"key":"BFncprheum0855_CR63","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.4049\/jimmunol.173.4.2280","volume":"173","author":"N Giarratana","year":"2004","unstructured":"Giarratana N  et al. (2004) A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 173: 2280\u20132287","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2337\/db07-1095","volume":"57","author":"C Gysemans","year":"2008","unstructured":"Gysemans C  et al. (2008) Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 57: 269\u2013275","journal-title":"Diabetes"},{"key":"BFncprheum0855_CR65","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jnr.20826","volume":"83","author":"G Muthian","year":"2006","unstructured":"Muthian G  et al. (2006) 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFNgamma axis leading to TH1 response in experimental allergic encephalomyelitis. J Neurosci Res 83: 1299\u20131309","journal-title":"J Neurosci Res"},{"key":"BFncprheum0855_CR66","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","volume":"177","author":"KM Spach","year":"2006","unstructured":"Spach KM  et al. (2006) IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177: 6030\u20136037","journal-title":"J Immunol"},{"key":"BFncprheum0855_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2172-8-5","volume":"8","author":"M Froicu","year":"2007","unstructured":"Froicu M and Cantorna MT (2007) Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8: 5","journal-title":"BMC Immunol"},{"key":"BFncprheum0855_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/eji.200425491","volume":"35","author":"Y Zhu","year":"2005","unstructured":"Zhu Y  et al. (2005) Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 35: 217\u2013224","journal-title":"Eur J Immunol"},{"key":"BFncprheum0855_CR69","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.ju.0000136002.76898.04","volume":"172","author":"MA Pontari","year":"2004","unstructured":"Pontari MA and Ruggieri MR (2004) Mechanisms in prostatitis\/chronic pelvic pain syndrome. J Urol 172: 839\u2013845","journal-title":"J Urol"},{"key":"BFncprheum0855_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1530\/eje.0.1500591","volume":"150","author":"C Crescioli","year":"2004","unstructured":"Crescioli C  et al. (2004) Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. Eur J Endocrinol 150: 591\u2013603","journal-title":"Eur J Endocrinol"},{"key":"BFncprheum0855_CR71","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1517\/14728222.10.5.735","volume":"10","author":"MJ Campbell","year":"2006","unstructured":"Campbell MJ and Adorini L (2006) The vitamin D receptor as a therapeutic target. Expert Opin Ther Targets 10: 735\u2013748","journal-title":"Expert Opin Ther Targets"},{"key":"BFncprheum0855_CR72","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/j.1523-1755.2005.00651.x","volume":"68","author":"A Levin","year":"2005","unstructured":"Levin A and Li YC (2005) Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease. Kidney Int 68: 1973\u20131981","journal-title":"Kidney Int"},{"key":"BFncprheum0855_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MCO.0b013e3282f2f4dd","volume":"11","author":"ED Michos","year":"2008","unstructured":"Michos ED and Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11: 7\u201312","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFncprheum0855_CR74","first-page":"363","volume":"5","author":"AV Kalueff","year":"2006","unstructured":"Kalueff AV  et al. (2006) The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets 5: 363\u2013371","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0855","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:13:27Z","timestamp":1684444407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BFncprheum0855"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0855","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}